Ketamine is increasingly being used as an off-label treatment for depression, but researchers have found it might not provide any long term benefits.
Depression has been recognised by the World Health Organization (WHO) as a leading cause of disability globally, with about one in six adults reporting moderate to severe depressive symptoms in the UK.
